Skip to main content

Abstract

Radiation therapy plays an integral role in the management of breast cancer at all stages, as definitive, adjuvant and as palliative treatment for metastatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al: Accelerated treatment of breast cancer. J Clin Oncol 2001;19:1993–2001.

    CAS  PubMed  Google Scholar 

  2. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al: Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94:1143–50.

    PubMed  Google Scholar 

  3. Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, et al: Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys 2000;47:1191–200.

    CAS  PubMed  Google Scholar 

  4. Stibbe: The internal mammary lymphatic glands, anatomy 1918:52–258.

    Google Scholar 

  5. Lichter AS, Fraass BA, Yanke B: Treatment Techniques in the Conservative Management of Breast Cancer. Semin Radiat Oncol 1992;2:94–106.

    Article  PubMed  Google Scholar 

  6. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, et al: The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000;55:219–32.

    Article  CAS  PubMed  Google Scholar 

  7. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15:963–8.

    CAS  PubMed  Google Scholar 

  8. Irvine DM, Vincent L, Graydon JE, Bubela N: Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 1998;21:127–35.

    Article  CAS  PubMed  Google Scholar 

  9. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B, et al: Edema of the arm as a function of the extent of axillary surgery in patients with stage I–II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575–82.

    CAS  PubMed  Google Scholar 

  10. Liljegren G, Holmberg L: Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 1997;33:193–9.

    Article  CAS  PubMed  Google Scholar 

  11. Segerstrom K, Bjerle P, Graffman S, Nystrom A: Factors that influence the incidence of brachial oedema after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg 1992;26:223–7.

    Article  CAS  PubMed  Google Scholar 

  12. Pierce LJ, Oberman HA, Strawderman MH, Lichter AS: Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995;33:253–9.

    CAS  PubMed  Google Scholar 

  13. Pierce SM, Recht A, Lingos TI, Abner A, Vicini F, Silver B, et al: Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992;23:915–23.

    CAS  PubMed  Google Scholar 

  14. Olsen NK, Pfeiffer P, Johannsen L, Schroder H, Rose C: Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993;26:43–9.

    CAS  PubMed  Google Scholar 

  15. Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR: Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:355–60.

    CAS  PubMed  Google Scholar 

  16. Marks LB, Clough R, Fan M, Hollis MG, Bowen D, Lucas A, et al: Radiation-induced pneumonitis following tangential breast/chest wall irradiation. Int J Radiat Oncol Biol Phys 2000;48 (Suppl):294 (abstract).

    Google Scholar 

  17. Wong JS, Recht A, Beard CJ, Busse PM, Cady B, Chaffey JT, et al: Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys 1997;39:915–20.

    CAS  PubMed  Google Scholar 

  18. Freedman GM, Fowble BL, Nicolaou N, Sigurdson ER, Torosian MH, Boraas MC, et al: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000;46:805–14.

    CAS  PubMed  Google Scholar 

  19. Shapiro CL, Hardenbergh PH, Gelman R, Blanks D, Hauptman P, Recht A, et al: Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 1998;16:3493–501.

    CAS  PubMed  Google Scholar 

  20. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E: Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999;43:755–62.

    CAS  PubMed  Google Scholar 

  21. Taghian A, de Vathaire F, Terrier P, Le M, Auquier A, Mouriesse H, et al: Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991;21:361–7.

    CAS  PubMed  Google Scholar 

  22. Vallis K, Pintilie M, Chong N, al e: Assessment of coronary heart disease morbidity and mortality following radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 2000;66:144 (abstract).

    Google Scholar 

  23. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL: Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986;121:1303–7.

    Article  CAS  PubMed  Google Scholar 

  24. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI: Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22–25, 1999. Cancer 2000;88:946–54.

    Article  CAS  PubMed  Google Scholar 

  25. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581–6.

    Article  CAS  PubMed  Google Scholar 

  26. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441–52.

    CAS  PubMed  Google Scholar 

  27. Winchester DP, Menck HR, Osteen RT, Kraybill W: Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol 1995;2:207–13.

    Article  CAS  PubMed  Google Scholar 

  28. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS: Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15–20.

    Article  CAS  PubMed  Google Scholar 

  29. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for Tla breast carcinoma. Is it indicated? Cancer 1994;73:664–7.

    Article  CAS  PubMed  Google Scholar 

  30. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, et al: Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63:731–41.

    Article  CAS  PubMed  Google Scholar 

  31. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP)Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 1995;75:1310–9.

    Article  CAS  PubMed  Google Scholar 

  32. Haagensen C, Bodian, C, Haagensen, DE: Lobular neoplasia (lobular carinoma in situ) breast carcinoma: risk and detection. Philadelphia: WB Saunders; 1981.

    Google Scholar 

  33. Group EBCTC: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group. Nngl J Med 1995;333:1444–55.

    Google Scholar 

  34. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  35. Wallgren A, Bernier J, Gelber RD, Goldhirsch A, Roncadin M, Joseph D, et al: Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys 1996;35:649–59.

    CAS  PubMed  Google Scholar 

  36. Valagussa P, Zambetti M, Biasi S, Moliterni A, Zucali R, Bonadonna G: Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Ann Oncol 1994;5:209–16.

    CAS  PubMed  Google Scholar 

  37. Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491–512.

    CAS  Google Scholar 

  38. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674–81.

    Article  CAS  PubMed  Google Scholar 

  39. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917–24.

    Article  CAS  PubMed  Google Scholar 

  40. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181–7.

    Article  CAS  PubMed  Google Scholar 

  41. Silverstein MJ, Skinner KA, Lomis TJ: Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767–72.

    Article  CAS  PubMed  Google Scholar 

  42. Ravdin P: Can patient and tumor characteristics allow prediction of axillary lymph node status? Breast Discovery, 1998, p. 141.

    Google Scholar 

  43. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, et al: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574–81.

    Article  CAS  PubMed  Google Scholar 

  44. Fowble B, Solin LJ, Schultz DJ, Goodman RL: Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 1989;17:703–10.

    CAS  PubMed  Google Scholar 

  45. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K: Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 1988;14:407–12.

    CAS  PubMed  Google Scholar 

  46. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765–72.

    CAS  PubMed  Google Scholar 

  47. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S: Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995;13:2869–78.

    CAS  PubMed  Google Scholar 

  48. Hay ward J, Caleffi M: The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award. Arch Surg 1987;122:1244–7.

    CAS  PubMed  Google Scholar 

  49. Schmoor C, Sauerbrei W, Bastert G, Schumacher M: Role of isolated locoregional ecurrence of breast cancer: results of four prospective studies. J Clin Oncol 2000;18:1696–708.

    CAS  PubMed  Google Scholar 

  50. Morrow M, Foster RS, Jr.: Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg 1981; 116:748–51.

    CAS  PubMed  Google Scholar 

  51. Harlow S, Krag D, Weaver D, Ashikaga T: Extra-Axillary Sentinel Lymph Nodes in Breast Cancer. Breast Cancer 1999;6:159–65.

    Article  PubMed  Google Scholar 

  52. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, et al: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000; 18:2817–27.

    CAS  PubMed  Google Scholar 

  53. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B: Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys 1990;19:851–8.

    CAS  PubMed  Google Scholar 

  54. Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL: The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 1991;21:299–310.

    CAS  PubMed  Google Scholar 

  55. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949–55.

    Article  CAS  PubMed  Google Scholar 

  56. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956–62.

    Article  CAS  PubMed  Google Scholar 

  57. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641–8.

    Article  CAS  PubMed  Google Scholar 

  58. Obedian E, Haffty BG: Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit? Int J Radiat Oncol Biol Phys 1999;44:997–1003.

    CAS  PubMed  Google Scholar 

  59. Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, et al: Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 2000;47:883–94.

    CAS  PubMed  Google Scholar 

  60. Yamashita TS, K et al: Efficacy of Loco-regional lymph nodes irradiation after mastectomy for breast with biopsy proven lymph nodes metastasis. Int J Radiat Oncol Biol Phys 1996;36:277.

    Article  Google Scholar 

  61. Smart CR, Byrne C, Smith RA, Garfinkel L, Letton AH, Dodd GD, et al: Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47:134–49.

    Article  CAS  PubMed  Google Scholar 

  62. Hortobagi GS, SE Strom, EA: Treatment of locally advanced and inflammatory breast cancer. In Harris J, Lippman, ME, Morrow, M, Osborne, CK, editor. Diseases of the Breast. Philadelphia: Lippincott Williams and Wilkins, 2000.

    Google Scholar 

  63. Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK: Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol 1999;16:95–103.

    Article  CAS  PubMed  Google Scholar 

  64. Perloff M, Lesnick GJ, Korzun A, Chu F, Holland JF, Thirlwell MP, et al: Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol 1988;6:261–9.

    CAS  PubMed  Google Scholar 

  65. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, et ak Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507–16.

    Article  CAS  PubMed  Google Scholar 

  66. Merajver SD, Weber BL, Cody R, Zhang D, Strawderman M, Calzone KA, et al: Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. J Clin Oncol 1997;15:2873–81.

    CAS  PubMed  Google Scholar 

  67. Graham MV, Perez CA, Kuske RR, Garcia DM, Fineberg B: Locally advanced (noninflammatory) carcinoma of the breast: results and comparison of various treatment modalities. Int J Radiat Oncol Biol Phys 1991;21:311–8.

    CAS  PubMed  Google Scholar 

  68. Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, et al: A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998;9.T 179–84.

    Article  Google Scholar 

  69. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, et al: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:1356–61.

    Article  CAS  PubMed  Google Scholar 

  70. Brito RA, Valero V, Buzdar AU, Booser DJ, Ames F, Strom E, et al: Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 2001;19:628–33.

    CAS  PubMed  Google Scholar 

  71. De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1978;1:53–9.

    Article  PubMed  Google Scholar 

  72. Olson JE, Neuberg D, Pandya KJ, Richter MP, Solin LJ, Gilchrist KW, et al: The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 1997;79:1138–49.

    Article  CAS  PubMed  Google Scholar 

  73. Berg JW, Hutter RV: Breast cancer. Cancer 1995;75:257–69.

    Article  CAS  PubMed  Google Scholar 

  74. Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD: Inflammatory breast arcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975–1992. Cancer 1998;82:2366–72.

    Article  CAS  PubMed  Google Scholar 

  75. Kleer CG, van Golen KL, Merajver SD: Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2000;2:423–9.

    Article  CAS  PubMed  Google Scholar 

  76. Lamb CC, Eberlein TJ, Parker LM, Silver B, Harris JR: Results of radical radiotherapy for inflammatory breast cancer. Am J Surg 1991;162:236–42.

    Article  CAS  PubMed  Google Scholar 

  77. Jaiyesimi IA, Buzdar AU, Hortobagyi G: Inflammatory breast cancer: a review. J Clin Oncol 1992;10:1014–24.

    CAS  PubMed  Google Scholar 

  78. Mazze RI, Kallen B: Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989;161:1178–85.

    CAS  PubMed  Google Scholar 

  79. Patchell R: Brain Metastases. Handbook of Neurology, 1997, p. 135.

    Google Scholar 

  80. Posner JB: Management of brain metastases. Rev Neurol 1992;148:477–87.

    CAS  PubMed  Google Scholar 

  81. Sawaya R, Bindal RK: Metastic brain tumors. In Kaye AL, ER, editor. Brain Tumors. Edinburgh: Churchill Livingstone, 1995, p. 923.

    Google Scholar 

  82. Sneed PK, Larson DA, Wara WM: Radiotherapy for cerebral metastases. Neurosurg Clin N Am 1996;7:505–15.

    CAS  PubMed  Google Scholar 

  83. Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 1980;7:529–41.

    Article  CAS  PubMed  Google Scholar 

  84. Levin V, Meghzifene, A, Izewska, J, Tatsuzaki, H: Improving Cancer Care: Increased need for radiotherapy in the developing countries, 2001, p. 25–32.

    Google Scholar 

  85. Ayanian JZ, Guadagnoli E: Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat 1996;40:65–74.

    Article  CAS  PubMed  Google Scholar 

  86. Joslyn SA: Racial differences in treatment and survival from early-stage breast rcinoma. Cancer 2002;95:1759–66.

    Article  PubMed  Google Scholar 

  87. Macbeth FR, Bolger JJ, Hopwood P, Bleehen NM, Cartmell J, Girling DJ, et al: Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol 1996;8:167–75.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer

About this chapter

Cite this chapter

Agboola, O. (2006). Radiotherapy of Breast Cancer. In: Williams, C.K.O., Olopade, O.I., Falkson, C.I. (eds) Breast Cancer in Women of African Descent. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-3664-4_7

Download citation

Publish with us

Policies and ethics